Previous 10 | Next 10 |
ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwri...
ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the securities class actions over the company’s 2018 initial public offering brought in the f...
2023-08-09 22:14:10 ET electroCore, Inc. (ECOR) Q2 2023 Earnings Conference Call August 09, 2023, 16:30 ET Company Participants Daniel Goldberger - CEO & Director Brian Posner - CFO & Corporate Secretary Conference Call Participants John Vandermos...
2023-08-09 16:15:16 ET ElectroCore press release ( NASDAQ: ECOR ): Q2 GAAP EPS of -$1.03 misses by $0.07 . Revenue of $3.6M (+66.7% Y/Y) beats by $0.09M . For further details see: ElectroCore GAAP EPS of -$1.03 misses by $0.07, revenue of $3.6M beats by $...
Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ROCKAWAY, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Na...
2023-08-08 17:35:55 ET ElectroCore ( NASDAQ: ECOR ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, after market close. The consensus EPS Estimate is -$0.93 (-1062.5% Y/Y) and the consensus Revenue Estimate is $3.51M (+62.5% Y/Y).Over the last 1 year, ...
ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of the market on Wed...
2023-08-01 07:27:07 ET Commercial-stage bioelectronic medicine and wellness company electroCore ( NASDAQ: ECOR ) will issue and sell to certain institutional and accredited investors an aggregate of 1.68M shares and warrants to purchase up to an aggregate of 837,955 shares. ...
ROCKAWAY, N.J., July 31, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to certain institutional and accred...
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer reviewed manuscript, Effect of Transcutaneous Cervical Vagus Nerve Stimulation on Declarative and Wo...
News, Short Squeeze, Breakout and More Instantly...
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM™, a non-invasive vagus nerve stimulat...
2024-06-11 04:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced the closing of its previously announced registered direct offering of 22...